Juvenile Dermatomyositis clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
open to eligible people ages 6-75
RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
at UC Irvine UCSF
Our lead scientists for Juvenile Dermatomyositis research studies include Susan Kim, MD, MMSc Tahseen Mozaffar, MD.
Last updated: